世界の肺炎球菌コンジュゲートワクチン（PCV）市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Pneumococcal Conjugate Vaccine (PCV) Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5956 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、肺炎球菌コンジュゲートワクチン（PCV）の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（23価ワクチン、10価ワクチン、7価ワクチン、13価ワクチン）、用途別市場規模（子供用、大人用）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・肺炎球菌コンジュゲートワクチン（PCV）の市場動向 ・企業の競争状況、市場シェア ・肺炎球菌コンジュゲートワクチン（PCV）の種類別市場規模と予測2016-2027（23価ワクチン、10価ワクチン、7価ワクチン、13価ワクチン） ・肺炎球菌コンジュゲートワクチン（PCV）の用途別市場規模と予測2016-2027（子供用、大人用） ・肺炎球菌コンジュゲートワクチン（PCV）の北米市場規模2016-2027（アメリカ、カナダ） ・肺炎球菌コンジュゲートワクチン（PCV）の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・肺炎球菌コンジュゲートワクチン（PCV）のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・肺炎球菌コンジュゲートワクチン（PCV）の中南米市場規模2016-2027（メキシコ、ブラジル） ・肺炎球菌コンジュゲートワクチン（PCV）の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Pfizer、GSK、Sanofi、Merck、Walvax Biotechnology、Royal (Wuxi) Bio-Pharmaceutical、Zhifei Biologic、Serum Institute of India） ・結論

Market Analysis and Insights: Global Pneumococcal Conjugate Vaccine (PCV) Market
The global Pneumococcal Conjugate Vaccine (PCV) market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Pneumococcal Conjugate Vaccine (PCV) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Pneumococcal Conjugate Vaccine (PCV) market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Pneumococcal Conjugate Vaccine (PCV) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Pneumococcal Conjugate Vaccine (PCV) market.

Global Pneumococcal Conjugate Vaccine (PCV) Scope and Market Size
Pneumococcal Conjugate Vaccine (PCV) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Pneumococcal Conjugate Vaccine (PCV) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
23-valent Vaccine
10-valent Vaccine
7-valent Vaccine
13-valent Vaccine

Segment by Application
Child
Adult

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Pfizer
GSK
Sanofi
Merck
Walvax Biotechnology
Royal (Wuxi) Bio-Pharmaceutical
Zhifei Biologic
Serum Institute of India

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pneumococcal Conjugate Vaccine (PCV) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 23-valent Vaccine
1.2.3 10-valent Vaccine
1.2.4 7-valent Vaccine
1.2.5 13-valent Vaccine
1.3 Market by Application
1.3.1 Global Pneumococcal Conjugate Vaccine (PCV) Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Child
1.3.3 Adult
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Pneumococcal Conjugate Vaccine (PCV) Market Perspective (2016-2027)
2.2 Pneumococcal Conjugate Vaccine (PCV) Growth Trends by Regions
2.2.1 Pneumococcal Conjugate Vaccine (PCV) Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Pneumococcal Conjugate Vaccine (PCV) Historic Market Share by Regions (2016-2021)
2.2.3 Pneumococcal Conjugate Vaccine (PCV) Forecasted Market Size by Regions (2022-2027)
2.3 Pneumococcal Conjugate Vaccine (PCV) Industry Dynamic
2.3.1 Pneumococcal Conjugate Vaccine (PCV) Market Trends
2.3.2 Pneumococcal Conjugate Vaccine (PCV) Market Drivers
2.3.3 Pneumococcal Conjugate Vaccine (PCV) Market Challenges
2.3.4 Pneumococcal Conjugate Vaccine (PCV) Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Pneumococcal Conjugate Vaccine (PCV) Players by Revenue
3.1.1 Global Top Pneumococcal Conjugate Vaccine (PCV) Players by Revenue (2016-2021)
3.1.2 Global Pneumococcal Conjugate Vaccine (PCV) Revenue Market Share by Players (2016-2021)
3.2 Global Pneumococcal Conjugate Vaccine (PCV) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Pneumococcal Conjugate Vaccine (PCV) Revenue
3.4 Global Pneumococcal Conjugate Vaccine (PCV) Market Concentration Ratio
3.4.1 Global Pneumococcal Conjugate Vaccine (PCV) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pneumococcal Conjugate Vaccine (PCV) Revenue in 2020
3.5 Pneumococcal Conjugate Vaccine (PCV) Key Players Head office and Area Served
3.6 Key Players Pneumococcal Conjugate Vaccine (PCV) Product Solution and Service
3.7 Date of Enter into Pneumococcal Conjugate Vaccine (PCV) Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Pneumococcal Conjugate Vaccine (PCV) Breakdown Data by Type
4.1 Global Pneumococcal Conjugate Vaccine (PCV) Historic Market Size by Type (2016-2021)
4.2 Global Pneumococcal Conjugate Vaccine (PCV) Forecasted Market Size by Type (2022-2027)

5 Pneumococcal Conjugate Vaccine (PCV) Breakdown Data by Application
5.1 Global Pneumococcal Conjugate Vaccine (PCV) Historic Market Size by Application (2016-2021)
5.2 Global Pneumococcal Conjugate Vaccine (PCV) Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Pneumococcal Conjugate Vaccine (PCV) Market Size (2016-2027)
6.2 North America Pneumococcal Conjugate Vaccine (PCV) Market Size by Type
6.2.1 North America Pneumococcal Conjugate Vaccine (PCV) Market Size by Type (2016-2021)
6.2.2 North America Pneumococcal Conjugate Vaccine (PCV) Market Size by Type (2022-2027)
6.2.3 North America Pneumococcal Conjugate Vaccine (PCV) Market Size by Type (2016-2027)
6.3 North America Pneumococcal Conjugate Vaccine (PCV) Market Size by Application
6.3.1 North America Pneumococcal Conjugate Vaccine (PCV) Market Size by Application (2016-2021)
6.3.2 North America Pneumococcal Conjugate Vaccine (PCV) Market Size by Application (2022-2027)
6.3.3 North America Pneumococcal Conjugate Vaccine (PCV) Market Size by Application (2016-2027)
6.4 North America Pneumococcal Conjugate Vaccine (PCV) Market Size by Country
6.4.1 North America Pneumococcal Conjugate Vaccine (PCV) Market Size by Country (2016-2021)
6.4.2 North America Pneumococcal Conjugate Vaccine (PCV) Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Pneumococcal Conjugate Vaccine (PCV) Market Size (2016-2027)
7.2 Europe Pneumococcal Conjugate Vaccine (PCV) Market Size by Type
7.2.1 Europe Pneumococcal Conjugate Vaccine (PCV) Market Size by Type (2016-2021)
7.2.2 Europe Pneumococcal Conjugate Vaccine (PCV) Market Size by Type (2022-2027)
7.2.3 Europe Pneumococcal Conjugate Vaccine (PCV) Market Size by Type (2016-2027)
7.3 Europe Pneumococcal Conjugate Vaccine (PCV) Market Size by Application
7.3.1 Europe Pneumococcal Conjugate Vaccine (PCV) Market Size by Application (2016-2021)
7.3.2 Europe Pneumococcal Conjugate Vaccine (PCV) Market Size by Application (2022-2027)
7.3.3 Europe Pneumococcal Conjugate Vaccine (PCV) Market Size by Application (2016-2027)
7.4 Europe Pneumococcal Conjugate Vaccine (PCV) Market Size by Country
7.4.1 Europe Pneumococcal Conjugate Vaccine (PCV) Market Size by Country (2016-2021)
7.4.2 Europe Pneumococcal Conjugate Vaccine (PCV) Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Pneumococcal Conjugate Vaccine (PCV) Market Size (2016-2027)
8.2 Asia-Pacific Pneumococcal Conjugate Vaccine (PCV) Market Size by Type
8.2.1 Asia-Pacific Pneumococcal Conjugate Vaccine (PCV) Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Pneumococcal Conjugate Vaccine (PCV) Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Pneumococcal Conjugate Vaccine (PCV) Market Size by Type (2016-2027)
8.3 Asia-Pacific Pneumococcal Conjugate Vaccine (PCV) Market Size by Application
8.3.1 Asia-Pacific Pneumococcal Conjugate Vaccine (PCV) Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Pneumococcal Conjugate Vaccine (PCV) Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Pneumococcal Conjugate Vaccine (PCV) Market Size by Application (2016-2027)
8.4 Asia-Pacific Pneumococcal Conjugate Vaccine (PCV) Market Size by Region
8.4.1 Asia-Pacific Pneumococcal Conjugate Vaccine (PCV) Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Pneumococcal Conjugate Vaccine (PCV) Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Pneumococcal Conjugate Vaccine (PCV) Market Size (2016-2027)
9.2 Latin America Pneumococcal Conjugate Vaccine (PCV) Market Size by Type
9.2.1 Latin America Pneumococcal Conjugate Vaccine (PCV) Market Size by Type (2016-2021)
9.2.2 Latin America Pneumococcal Conjugate Vaccine (PCV) Market Size by Type (2022-2027)
9.2.3 Latin America Pneumococcal Conjugate Vaccine (PCV) Market Size by Type (2016-2027)
9.3 Latin America Pneumococcal Conjugate Vaccine (PCV) Market Size by Application
9.3.1 Latin America Pneumococcal Conjugate Vaccine (PCV) Market Size by Application (2016-2021)
9.3.2 Latin America Pneumococcal Conjugate Vaccine (PCV) Market Size by Application (2022-2027)
9.3.3 Latin America Pneumococcal Conjugate Vaccine (PCV) Market Size by Application (2016-2027)
9.4 Latin America Pneumococcal Conjugate Vaccine (PCV) Market Size by Country
9.4.1 Latin America Pneumococcal Conjugate Vaccine (PCV) Market Size by Country (2016-2021)
9.4.2 Latin America Pneumococcal Conjugate Vaccine (PCV) Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Size (2016-2027)
10.2 Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Size by Type
10.2.1 Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Size by Type (2016-2027)
10.3 Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Size by Application
10.3.1 Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Size by Application (2016-2027)
10.4 Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Size by Country
10.4.1 Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Pneumococcal Conjugate Vaccine (PCV) Introduction
11.1.4 Pfizer Revenue in Pneumococcal Conjugate Vaccine (PCV) Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 GSK
11.2.1 GSK Company Details
11.2.2 GSK Business Overview
11.2.3 GSK Pneumococcal Conjugate Vaccine (PCV) Introduction
11.2.4 GSK Revenue in Pneumococcal Conjugate Vaccine (PCV) Business (2016-2021)
11.2.5 GSK Recent Development
11.3 Sanofi
11.3.1 Sanofi Company Details
11.3.2 Sanofi Business Overview
11.3.3 Sanofi Pneumococcal Conjugate Vaccine (PCV) Introduction
11.3.4 Sanofi Revenue in Pneumococcal Conjugate Vaccine (PCV) Business (2016-2021)
11.3.5 Sanofi Recent Development
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Merck Business Overview
11.4.3 Merck Pneumococcal Conjugate Vaccine (PCV) Introduction
11.4.4 Merck Revenue in Pneumococcal Conjugate Vaccine (PCV) Business (2016-2021)
11.4.5 Merck Recent Development
11.5 Walvax Biotechnology
11.5.1 Walvax Biotechnology Company Details
11.5.2 Walvax Biotechnology Business Overview
11.5.3 Walvax Biotechnology Pneumococcal Conjugate Vaccine (PCV) Introduction
11.5.4 Walvax Biotechnology Revenue in Pneumococcal Conjugate Vaccine (PCV) Business (2016-2021)
11.5.5 Walvax Biotechnology Recent Development
11.6 Royal (Wuxi) Bio-Pharmaceutical
11.6.1 Royal (Wuxi) Bio-Pharmaceutical Company Details
11.6.2 Royal (Wuxi) Bio-Pharmaceutical Business Overview
11.6.3 Royal (Wuxi) Bio-Pharmaceutical Pneumococcal Conjugate Vaccine (PCV) Introduction
11.6.4 Royal (Wuxi) Bio-Pharmaceutical Revenue in Pneumococcal Conjugate Vaccine (PCV) Business (2016-2021)
11.6.5 Royal (Wuxi) Bio-Pharmaceutical Recent Development
11.7 Zhifei Biologic
11.7.1 Zhifei Biologic Company Details
11.7.2 Zhifei Biologic Business Overview
11.7.3 Zhifei Biologic Pneumococcal Conjugate Vaccine (PCV) Introduction
11.7.4 Zhifei Biologic Revenue in Pneumococcal Conjugate Vaccine (PCV) Business (2016-2021)
11.7.5 Zhifei Biologic Recent Development
11.8 Serum Institute of India
11.8.1 Serum Institute of India Company Details
11.8.2 Serum Institute of India Business Overview
11.8.3 Serum Institute of India Pneumococcal Conjugate Vaccine (PCV) Introduction
11.8.4 Serum Institute of India Revenue in Pneumococcal Conjugate Vaccine (PCV) Business (2016-2021)
11.8.5 Serum Institute of India Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Pneumococcal Conjugate Vaccine (PCV) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of 23-valent Vaccine
Table 3. Key Players of 10-valent Vaccine
Table 4. Key Players of 7-valent Vaccine
Table 5. Key Players of 13-valent Vaccine
Table 6. Global Pneumococcal Conjugate Vaccine (PCV) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Pneumococcal Conjugate Vaccine (PCV) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Pneumococcal Conjugate Vaccine (PCV) Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Pneumococcal Conjugate Vaccine (PCV) Market Share by Regions (2016-2021)
Table 10. Global Pneumococcal Conjugate Vaccine (PCV) Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Pneumococcal Conjugate Vaccine (PCV) Market Share by Regions (2022-2027)
Table 12. Pneumococcal Conjugate Vaccine (PCV) Market Trends
Table 13. Pneumococcal Conjugate Vaccine (PCV) Market Drivers
Table 14. Pneumococcal Conjugate Vaccine (PCV) Market Challenges
Table 15. Pneumococcal Conjugate Vaccine (PCV) Market Restraints
Table 16. Global Pneumococcal Conjugate Vaccine (PCV) Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Pneumococcal Conjugate Vaccine (PCV) Market Share by Players (2016-2021)
Table 18. Global Top Pneumococcal Conjugate Vaccine (PCV) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pneumococcal Conjugate Vaccine (PCV) as of 2020)
Table 19. Ranking of Global Top Pneumococcal Conjugate Vaccine (PCV) Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Pneumococcal Conjugate Vaccine (PCV) Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Pneumococcal Conjugate Vaccine (PCV) Product Solution and Service
Table 23. Date of Enter into Pneumococcal Conjugate Vaccine (PCV) Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Pneumococcal Conjugate Vaccine (PCV) Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Pneumococcal Conjugate Vaccine (PCV) Revenue Market Share by Type (2016-2021)
Table 27. Global Pneumococcal Conjugate Vaccine (PCV) Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Pneumococcal Conjugate Vaccine (PCV) Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Pneumococcal Conjugate Vaccine (PCV) Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Pneumococcal Conjugate Vaccine (PCV) Revenue Market Share by Application (2016-2021)
Table 31. Global Pneumococcal Conjugate Vaccine (PCV) Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Pneumococcal Conjugate Vaccine (PCV) Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Pneumococcal Conjugate Vaccine (PCV) Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Pneumococcal Conjugate Vaccine (PCV) Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Pneumococcal Conjugate Vaccine (PCV) Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Pneumococcal Conjugate Vaccine (PCV) Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Pneumococcal Conjugate Vaccine (PCV) Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Pneumococcal Conjugate Vaccine (PCV) Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Pneumococcal Conjugate Vaccine (PCV) Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Pneumococcal Conjugate Vaccine (PCV) Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Pneumococcal Conjugate Vaccine (PCV) Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Pneumococcal Conjugate Vaccine (PCV) Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Pneumococcal Conjugate Vaccine (PCV) Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Pneumococcal Conjugate Vaccine (PCV) Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Pneumococcal Conjugate Vaccine (PCV) Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Pneumococcal Conjugate Vaccine (PCV) Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Pneumococcal Conjugate Vaccine (PCV) Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Pneumococcal Conjugate Vaccine (PCV) Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Pneumococcal Conjugate Vaccine (PCV) Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Pneumococcal Conjugate Vaccine (PCV) Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Pneumococcal Conjugate Vaccine (PCV) Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Pneumococcal Conjugate Vaccine (PCV) Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Pneumococcal Conjugate Vaccine (PCV) Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Pneumococcal Conjugate Vaccine (PCV) Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Pneumococcal Conjugate Vaccine (PCV) Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Pneumococcal Conjugate Vaccine (PCV) Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Size by Country (2022-2027) & (US$ Million)
Table 63. Pfizer Company Details
Table 64. Pfizer Business Overview
Table 65. Pfizer Pneumococcal Conjugate Vaccine (PCV) Product
Table 66. Pfizer Revenue in Pneumococcal Conjugate Vaccine (PCV) Business (2016-2021) & (US$ Million)
Table 67. Pfizer Recent Development
Table 68. GSK Company Details
Table 69. GSK Business Overview
Table 70. GSK Pneumococcal Conjugate Vaccine (PCV) Product
Table 71. GSK Revenue in Pneumococcal Conjugate Vaccine (PCV) Business (2016-2021) & (US$ Million)
Table 72. GSK Recent Development
Table 73. Sanofi Company Details
Table 74. Sanofi Business Overview
Table 75. Sanofi Pneumococcal Conjugate Vaccine (PCV) Product
Table 76. Sanofi Revenue in Pneumococcal Conjugate Vaccine (PCV) Business (2016-2021) & (US$ Million)
Table 77. Sanofi Recent Development
Table 78. Merck Company Details
Table 79. Merck Business Overview
Table 80. Merck Pneumococcal Conjugate Vaccine (PCV) Product
Table 81. Merck Revenue in Pneumococcal Conjugate Vaccine (PCV) Business (2016-2021) & (US$ Million)
Table 82. Merck Recent Development
Table 83. Walvax Biotechnology Company Details
Table 84. Walvax Biotechnology Business Overview
Table 85. Walvax Biotechnology Pneumococcal Conjugate Vaccine (PCV) Product
Table 86. Walvax Biotechnology Revenue in Pneumococcal Conjugate Vaccine (PCV) Business (2016-2021) & (US$ Million)
Table 87. Walvax Biotechnology Recent Development
Table 88. Royal (Wuxi) Bio-Pharmaceutical Company Details
Table 89. Royal (Wuxi) Bio-Pharmaceutical Business Overview
Table 90. Royal (Wuxi) Bio-Pharmaceutical Pneumococcal Conjugate Vaccine (PCV) Product
Table 91. Royal (Wuxi) Bio-Pharmaceutical Revenue in Pneumococcal Conjugate Vaccine (PCV) Business (2016-2021) & (US$ Million)
Table 92. Royal (Wuxi) Bio-Pharmaceutical Recent Development
Table 93. Zhifei Biologic Company Details
Table 94. Zhifei Biologic Business Overview
Table 95. Zhifei Biologic Pneumococcal Conjugate Vaccine (PCV) Product
Table 96. Zhifei Biologic Revenue in Pneumococcal Conjugate Vaccine (PCV) Business (2016-2021) & (US$ Million)
Table 97. Zhifei Biologic Recent Development
Table 98. Serum Institute of India Company Details
Table 99. Serum Institute of India Business Overview
Table 100. Serum Institute of India Revenue in Pneumococcal Conjugate Vaccine (PCV) Business (2016-2021) & (US$ Million)
Table 101. Serum Institute of India Recent Development
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pneumococcal Conjugate Vaccine (PCV) Market Share by Type: 2020 VS 2027
Figure 2. 23-valent Vaccine Features
Figure 3. 10-valent Vaccine Features
Figure 4. 7-valent Vaccine Features
Figure 5. 13-valent Vaccine Features
Figure 6. Global Pneumococcal Conjugate Vaccine (PCV) Market Share by Application: 2020 VS 2027
Figure 7. Child Case Studies
Figure 8. Adult Case Studies
Figure 9. Pneumococcal Conjugate Vaccine (PCV) Report Years Considered
Figure 10. Global Pneumococcal Conjugate Vaccine (PCV) Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Pneumococcal Conjugate Vaccine (PCV) Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Pneumococcal Conjugate Vaccine (PCV) Market Share by Regions: 2020 VS 2027
Figure 13. Global Pneumococcal Conjugate Vaccine (PCV) Market Share by Regions (2022-2027)
Figure 14. Global Pneumococcal Conjugate Vaccine (PCV) Market Share by Players in 2020
Figure 15. Global Top Pneumococcal Conjugate Vaccine (PCV) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pneumococcal Conjugate Vaccine (PCV) as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Pneumococcal Conjugate Vaccine (PCV) Revenue in 2020
Figure 17. Global Pneumococcal Conjugate Vaccine (PCV) Revenue Market Share by Type (2016-2021)
Figure 18. Global Pneumococcal Conjugate Vaccine (PCV) Revenue Market Share by Type (2022-2027)
Figure 19. North America Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Pneumococcal Conjugate Vaccine (PCV) Market Share by Type (2016-2027)
Figure 21. North America Pneumococcal Conjugate Vaccine (PCV) Market Share by Application (2016-2027)
Figure 22. North America Pneumococcal Conjugate Vaccine (PCV) Market Share by Country (2016-2027)
Figure 23. United States Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Pneumococcal Conjugate Vaccine (PCV) Market Share by Type (2016-2027)
Figure 27. Europe Pneumococcal Conjugate Vaccine (PCV) Market Share by Application (2016-2027)
Figure 28. Europe Pneumococcal Conjugate Vaccine (PCV) Market Share by Country (2016-2027)
Figure 29. Germany Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Pneumococcal Conjugate Vaccine (PCV) Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Pneumococcal Conjugate Vaccine (PCV) Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Pneumococcal Conjugate Vaccine (PCV) Market Share by Region (2016-2027)
Figure 39. China Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Pneumococcal Conjugate Vaccine (PCV) Market Share by Type (2016-2027)
Figure 47. Latin America Pneumococcal Conjugate Vaccine (PCV) Market Share by Application (2016-2027)
Figure 48. Latin America Pneumococcal Conjugate Vaccine (PCV) Market Share by Country (2016-2027)
Figure 49. Mexico Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Share by Country (2016-2027)
Figure 55. Turkey Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Pfizer Revenue Growth Rate in Pneumococcal Conjugate Vaccine (PCV) Business (2016-2021)
Figure 59. GSK Revenue Growth Rate in Pneumococcal Conjugate Vaccine (PCV) Business (2016-2021)
Figure 60. Sanofi Revenue Growth Rate in Pneumococcal Conjugate Vaccine (PCV) Business (2016-2021)
Figure 61. Merck Revenue Growth Rate in Pneumococcal Conjugate Vaccine (PCV) Business (2016-2021)
Figure 62. Walvax Biotechnology Revenue Growth Rate in Pneumococcal Conjugate Vaccine (PCV) Business (2016-2021)
Figure 63. Royal (Wuxi) Bio-Pharmaceutical Revenue Growth Rate in Pneumococcal Conjugate Vaccine (PCV) Business (2016-2021)
Figure 64. Zhifei Biologic Revenue Growth Rate in Pneumococcal Conjugate Vaccine (PCV) Business (2016-2021)
Figure 65. Serum Institute of India Revenue Growth Rate in Pneumococcal Conjugate Vaccine (PCV) Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

---